These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 7809930

  • 1. Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
    Huss R, Beckham C, Storb R, Deeg HJ.
    Transplantation; 1994 Dec 27; 58(12):1366-71. PubMed ID: 7809930
    [Abstract] [Full Text] [Related]

  • 2. Major histocompatibility complex class II molecules, hemopoiesis and the marrow microenvironment.
    Deeg HJ, Huss R.
    Bone Marrow Transplant; 1993 Nov 27; 12(5):425-30. PubMed ID: 8298551
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL.
    Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596
    [Abstract] [Full Text] [Related]

  • 7. Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.
    Yamaguchi M, McSweeney PA, Kimball L, Gersuk G, Hong DS, Kwok W, Storb R, Beckham C, Deeg HJ.
    Transplantation; 1999 Oct 27; 68(8):1161-71. PubMed ID: 10551646
    [Abstract] [Full Text] [Related]

  • 8. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H, LeGuern C, Sachs DH, Sykes M.
    Bone Marrow Transplant; 1996 Aug 27; 18(2):285-92. PubMed ID: 8864436
    [Abstract] [Full Text] [Related]

  • 9. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR, Taylor PA, Vallera DA.
    J Immunol; 1994 Apr 01; 152(7):3665-74. PubMed ID: 8144942
    [Abstract] [Full Text] [Related]

  • 10. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.
    Morris SC, Coffman RL, Finkelman FD.
    J Immunol; 1998 Apr 01; 160(7):3299-304. PubMed ID: 9531287
    [Abstract] [Full Text] [Related]

  • 11. Phenotype and function of CD4+ T cells in mice lacking invariant chain.
    Wong P, Rudensky AY.
    J Immunol; 1996 Mar 15; 156(6):2133-42. PubMed ID: 8690902
    [Abstract] [Full Text] [Related]

  • 12. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY, Krasinskas AM, Kreisel D, Popma SH, Rosengard BR.
    J Thorac Cardiovasc Surg; 2000 Dec 15; 120(6):1070-7. PubMed ID: 11088028
    [Abstract] [Full Text] [Related]

  • 13. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB, Cestari S.
    Cell Immunol; 1997 May 25; 178(1):79-90. PubMed ID: 9184701
    [Abstract] [Full Text] [Related]

  • 14. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 15. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
    Krasteva M, Kehren J, Horand F, Akiba H, Choquet G, Ducluzeau MT, Tédone R, Garrigue JL, Kaiserlian D, Nicolas JF.
    J Immunol; 1998 Feb 01; 160(3):1181-90. PubMed ID: 9570532
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H, Takeuchi Y, Shaffer J, Sykes M.
    Transplantation; 2006 Jul 27; 82(2):251-7. PubMed ID: 16858289
    [Abstract] [Full Text] [Related]

  • 17. A CD4 domain 1 CC' loop peptide analogue enhances engraftment in a murine model of bone marrow transplantation with sublethal conditioning.
    Varadi G, Friedman TM, Korngold R.
    Biol Blood Marrow Transplant; 2005 Dec 27; 11(12):979-87. PubMed ID: 16338620
    [Abstract] [Full Text] [Related]

  • 18. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W, Kotera Y, Koike N, Pilon-Thomas S, Mulé JJ.
    Biol Blood Marrow Transplant; 2004 Aug 27; 10(8):524-33. PubMed ID: 15282530
    [Abstract] [Full Text] [Related]

  • 19. Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients.
    Dulude G, Brochu S, Fontaine P, Baron C, Gyger M, Roy DC, Perreault C.
    Exp Hematol; 1997 Aug 27; 25(9):992-1004. PubMed ID: 9257813
    [Abstract] [Full Text] [Related]

  • 20. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
    Vallera DA, Taylor PA, Sprent J, Blazar BR.
    Transplantation; 1994 Jan 27; 57(2):249-56. PubMed ID: 7906058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.